Saving the Care Home healthcare segment – Technology, M&A and the State

David Grabowski, a Harvard Medical School professor who specialises in healthcare policy, in an interview with Yahoo Finance in July 2020 spoke to the crisis of the US care home industry pre-Covid. Prior to the pandemic care home facilities...

Continue reading →

Is the cost of monitoring employees at home worth the erosion of trust?

Venturebeat, a US tech website, raised potential concerns about the emergence of AI surveillance of employees at home. Employee monitoring from cameras to keyboard clicks is nothing new, but this is a potentially unwelcome extension. We think there is...

Continue reading →

AI beats human diagnostics

A team of researchers from Google Health, working closely with researchers from North America, published a report recently in JAMA Oncology that showcased how their Artificial Intelligence (AI) diagnostic systems outperformed general pathologists in determining the degree of advancement...

Continue reading →

Researchers say that our pain threshold can be linked to Neanderthal DNA

Researchers from the Max Planck Institute for Evolutionary Anthropology (Germany) and the Karolinska Institutet (Sweden) say that our pain threshold can be linked to Neanderthal DNA. Neanderthals, or Homo neanderthalensis, lived in Eurasia up until 40,000 years ago. Current thinking...

Continue reading →

Trials of a vaccine and a new drug raise hopes of beating Covid-19

Oxford University published a paper in the Lancet on their trial of a Covid-19 vaccine on the 20th of July 2020. Even though Oxford University has been researching a vaccine since January 2020 and AstraZeneca (AZN.L) rushed to get...

Continue reading →

Trump’s 4 Exec Orders to lower drugs prices and save $17bn – not what it seems

US President Trump signed four executive orders on the 24th July 2020 aimed at lowering drug prices and setting an International Price Index (IPI) for drugs. While the Covid-19 pandemic has muted calls for drug price reductions over the...

Continue reading →

Behavioural health coding double-accounted for in US official reports

In a University of Minnesota School of Public Health (SPH) recent publication in the American Journal of Public Health, it was reported that the US federal public health expenditure has been overestimated by at least 2x. In 2019, the US...

Continue reading →

What can ants and bees teach us about containing disease

Nathalie Stroeymeyt, a senior lecturer in the School of Biological Sciences at the University of Bristol, drew parallels from the guides to social distancing during the Covid-19 pandemic and how ants behave in a recent research study. The research was...

Continue reading →

Will the UK see medical cannabis prescribed instead of expensive and more damaging opioid drugs

A recently published white paper on medical cannabis from the Journal of Psychopharmacology has been produced and published recently presenting essential points on prescription of medical cannabinoids. See our exhibit 1 below for the 2019 value of the total...

Continue reading →

Have diagnostic sector producers hit the ‘jackpot’ with the Covid-19 tests

● Abbott Laboratories (ABT.IXIC) had sold over 40m Covid-19 diagnostic-tests by mid-July 2020. As the virus infected cases rise globally demand for tests is soaring. But are the tests efficacious and is this a new dawn for diagnostics companies...

Continue reading →